Antiproliferative Effect of 7-Ketositosterol in Breast and Liver Cancer Cells: Possible Impact on Ceramide, Extracellular Signal-Regulated Kinases, and Nuclear Factor Kappa B Signaling Pathways

  • Pharmaceuticals (Basel). 2024 Jul 1;17(7):860. doi: 10.3390/ph17070860.
Zerrin Barut  1 Mutay Aslan  2  3 Bürke Çırçırlı  3 Tuğçe Çeker  2 Çağatay Yılmaz  2
Affiliations
  • 1. Faculty of Dentistry, Antalya Bilim University, 07190 Antalya, Turkey.
  • 2. Department of Medical Biochemistry, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey.
  • 3. Department of Medical Biotechnology, Institute of Health Sciences, Akdeniz University, 07070 Antalya, Turkey.
Abstract

Background: This study aimed to examine the effect of 7-Ketositosterol (7-KSS), on sphingomyelin/ceramide metabolites and Apoptosis in human breast MCF-7 and human liver HepG2 Cancer cells. Methods: Anti-proliferative effects of 7-KSS treatment were assessed at different concentrations and periods. Cell viability was assessed through MTT analysis, whereas the levels of sphingosine-1-phosphate (S1P), sphingomyelins (SMs), and ceramides (CERs) were measured using LC-MS/MS. Phosphorylated 44/42 ERK1/2 and NF-κB p65 (Ser536) protein levels were measured by Western blot analysis and immunofluorescence staining. Apoptosis was evaluated by TUNEL staining and flow cytometric assessment of annexin-V and propidium iodide (PI) labeling. Results: Treatment with 7-KSS significantly decreased cell survival and S1P, p-44/42 ERK1/2, and p-NF-κB p65 protein levels in Cancer cells compared to controls. A substantial rise was detected in intracellular amounts of C16-C24 CERs and Apoptosis in Cancer cells incubated with 7-KSS. Conclusions: 7-KSS stimulated ceramide accumulation and Apoptosis while decreasing cell proliferation via downregulating S1P, p-44/42 ERK1/2, and p-NF-κB p65 protein levels.

Keywords
7-Ketositosterol; ERK; apoptosis; ceramide.
Products